2025 annual financial data
Sinovac Biotech 2025 Operating margin
Sinovac Biotech 2025 operating margin with verified reported values.
Direct answer
Operating margin was -75.47%.
Operating income was -291,322,000 USD and net income was -59,680,000 USD.
Operating cash flow was -510,485,000 USD.
Get free Sinovac Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 386,013,000 USD
- Operating income
- -291,322,000 USD
- Net income
- -59,680,000 USD
- Operating cash flow
- -510,485,000 USD